Search Within

Gregory J Riely

Formats
  1. Journal Article (295)
  2. Meeting Abstract (265)
  3. Book Section (16)
  4. Guidelines (16)
  5. Conference Paper (4)
  6. Review (4)
  7. Editorial (3)
  8. Correspondence (2)
  9. Book Whole (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (607)
  2. Solid Tumor Oncology Division (607)
  3. Thoracic Oncology (607)
  4. Department of Pathology and Laboratory Medicine (263)
  5. GSK Faculty (248)
  6. Human Oncology and Pathogenesis Program (223)

More Groups

People
  1. Mark Kris (222)
  2. Marc Ladanyi (188)
  3. Helena Yu (108)
  4. Maria Arcila (85)
  5. Vincent Miller (79)
  6. Charles Rudin (76)

More People

Years
  1. 2025 (11)
  2. 2024 (25)
  3. 2023 (45)
  4. 2022 (39)
  5. 2021 (41)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (157)
  2. Journal of Thoracic Oncology (113)
  3. Clinical Cancer Research (46)
  4. Annals of Oncology (32)
  5. Journal of the National Comprehensive Cancer Network (27)
  6. Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (175)
  2. Elsevier Inc. (138)
  3. American Association for Cancer Research (77)
  4. Oxford University Press (39)
  5. Harborside Press (27)
  6. Elsevier Science, Inc. (23)

More Publishers

Results (607)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel crizotinib-resistant solvent-front mutation responsive to cabozantinib therapy in a patient with ROS1-rearranged lung cancer
    Journal Article

    Drilon, A.; Somwar, R.; Wagner, J. P.; Vellore, N. A.; Eide, C. A.; Zabriskie, M. S.; Arcila, M. E.; Hechtman, J. F.; Wang, L.; Smith, R. S.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): Updated results from the multicentre, open-label, phase 1 trial
    Journal Article

    Kim, D. W.; Mehra, R.; Tan, D. S. W.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; Riely, G. J.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Non-small cell lung cancer, version 4.2016
    Journal Article

    Ettinger, D. S.; Wood, D. E.; Akerley, W.; Bazhenova, L. A.; Borghaei, H.; Camidge, D. R.; Cheney, R. T.; Chirieac, L. R.; D'Amico, T. A.; Dilling, T. J.; more...
    Journal of the National Comprehensive Cancer Network (2016)

    Fulltext@MSK | Save
  • Detection of T790M, the acquired resistance EGFR mutation, by tumor biopsy versus noninvasive blood-based analyses
    Journal Article

    Sundaresan, T. K.; Sequist, L. V.; Heymach, J. V.; Riely, G. J.; Jänne, P. A.; Koch, W. H.; Sullivan, J. P.; Fox, D. B.; Maher, R.; Muzikansky, A.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: A single-group, multicentre, phase 2 trial
    Journal Article

    Shaw, A. T.; Gandhi, L.; Gadgeel, S.; Riely, G. J.; Cetnar, J.; West, H.; Camidge, D. R.; Socinski, M. A.; Chiappori, A.; Mekhail, T.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save
  • Counterpoints: Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations?—No, EGFR TKIs should be reserved for patients with EGFR mutations
    Journal Article

    Riely, G. J.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • Pulmonary blastoma
    Book Section

    Nakatani, Y.; Koss, M. N.; Kerr, K. M.; Austin, J. H. M.; Brambilla, E.; Geisinger, K.; Nicholson, A. G.; Pelosi, G.; Powell, C. A.; Rami-Porta, R.; more...
    In Travis, W. D.; Brambilla, E.; Burke, A. P.; Marx, A.; Nicholson, A. G. (Eds.) WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed (2015)

    Fulltext@MSK | Save
  • Carcinoma
    Book Section

    Koss, M. N.; Kerr, K. M.; Pelosi, G.; Austin, J. H. M.; Brambilla, E.; Geisinger, K.; Nicholson, A. G.; Powell, C. A.; Rami-Porta, R.; Riely, G.; more...
    In Travis, W. D.; Brambilla, E.; Burke, A. P.; Marx, A.; Nicholson, A. G. (Eds.) WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed (2015)

    Fulltext@MSK | Save
  • Pleomorphic, spindle cell, and giant cell carcinoma
    Book Section

    Kerr, K. M.; Pelosi, G.; Austin, J. H. M.; Brambilla, E.; Geisinger, K.; Jambhekar, N. A.; Jett, J.; Koss, M. N.; Nicholson, A. G.; Powell, C. A.; more...
    In Travis, W. D.; Brambilla, E.; Burke, A. P.; Marx, A.; Nicholson, A. G. (Eds.) WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed (2015)

    Fulltext@MSK | Save
  • Adenosquamous carcinoma
    Book Section

    Yatabe, Y.; Brambilla, E.; Rekhtman, N.; Aisner, S. C.; Caporaso, N. E.; Gonzalez, S.; Nicholson, A. G.; Powell, C. A.; Riely, G.; Seiwerth, S.; more...
    In Travis, W. D.; Brambilla, E.; Burke, A. P.; Marx, A.; Nicholson, A. G. (Eds.) WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed (2015)

    Fulltext@MSK | Save